These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 25246772

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus.
    Taylor DO, Barr ML, Radovancevic B, Renlund DG, Mentzer RM, Smart FW, Tolman DE, Frazier OH, Young JB, VanVeldhuisen P.
    J Heart Lung Transplant; 1999 Apr; 18(4):336-45. PubMed ID: 10226898
    [Abstract] [Full Text] [Related]

  • 23. Molecular and structural consequences of early renal allograft injury.
    Baboolal K, Jones GA, Janezic A, Griffiths DR, Jurewicz WA.
    Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
    [Abstract] [Full Text] [Related]

  • 24. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
    Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
    [Abstract] [Full Text] [Related]

  • 25. Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients--a large European trial.
    Grimm M, Rinaldi M, Yonan NA, Arpesella G, Arizón Del Prado JM, Pulpón LA, Villemot JP, Frigerio M, Rodriguez Lambert JL, Crespo-Leiro MG, Almenar L, Duveau D, Ordonez-Fernandez A, Gandjbakhch J, Maccherini M, Laufer G.
    Am J Transplant; 2006 Jun 15; 6(6):1387-97. PubMed ID: 16686762
    [Abstract] [Full Text] [Related]

  • 26. [Evaluation of immunosuppressive treatment on homocystein levels in patients after kidney transplantation during a 2 year observation period].
    Aksamit D, Janda K, Kuźniewski M, Krzanowski M, Ignacak E, Betkowska-Prokop A, Chowaniec E, Sułowicz W.
    Przegl Lek; 2012 Jun 15; 69(11):1175-9. PubMed ID: 23646442
    [Abstract] [Full Text] [Related]

  • 27. Optimization of the immunosuppressive protocol after lung transplantation.
    Reichenspurner H, Kur F, Treede H, Meiser BM, Deutsch O, Welz A, Vogelmeier C, Schwaiblmair M, Müller C, Fürst H, Briegel J, Reichart B.
    Transplantation; 1999 Jul 15; 68(1):67-71. PubMed ID: 10428269
    [Abstract] [Full Text] [Related]

  • 28. Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.
    Jones-Hughes T, Snowsill T, Haasova M, Coelho H, Crathorne L, Cooper C, Mujica-Mota R, Peters J, Varley-Campbell J, Huxley N, Moore J, Allwood M, Lowe J, Hyde C, Hoyle M, Bond M, Anderson R.
    Health Technol Assess; 2016 Aug 15; 20(62):1-594. PubMed ID: 27578428
    [Abstract] [Full Text] [Related]

  • 29. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine.
    Stegall MD, Simon M, Wachs ME, Chan L, Nolan C, Kam I.
    Transplantation; 1997 Dec 27; 64(12):1695-700. PubMed ID: 9422404
    [Abstract] [Full Text] [Related]

  • 30. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ, Rossi AF, Courtney M, Gelb BD.
    J Heart Lung Transplant; 1998 Dec 27; 17(12):1195-200. PubMed ID: 9883760
    [Abstract] [Full Text] [Related]

  • 31. Incidence of malignant neoplasia after heart transplantation--a comparison between cyclosporine a and tacrolimus.
    Fuchs U, Klein S, Zittermann A, Ensminger SM, Schulz U, Gummert JF.
    Ann Transplant; 2014 Jun 23; 19():300-4. PubMed ID: 24953848
    [Abstract] [Full Text] [Related]

  • 32. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.
    Stegall MD, Wachs ME, Everson G, Steinberg T, Bilir B, Shrestha R, Karrer F, Kam I.
    Transplantation; 1997 Dec 27; 64(12):1755-60. PubMed ID: 9422416
    [Abstract] [Full Text] [Related]

  • 33. An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients.
    Sommerer C, Suwelack B, Dragun D, Schenker P, Hauser IA, Witzke O, Hugo C, Kamar N, Merville P, Junge M, Thaiss F, Nashan B, Athena Study Group.
    Kidney Int; 2019 Jul 27; 96(1):231-244. PubMed ID: 31027892
    [Abstract] [Full Text] [Related]

  • 34. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.
    Filler G, Webb NJ, Milford DV, Watson AR, Gellermann J, Tyden G, Grenda R, Vondrak K, Hughes D, Offner G, Griebel M, Brekke IB, McGraw M, Balzar E, Friman S, Trompeter R.
    Pediatr Transplant; 2005 Aug 27; 9(4):498-503. PubMed ID: 16048603
    [Abstract] [Full Text] [Related]

  • 35. Evolution of rejection rates and kidney graft survival: a historical analysis.
    Marcén R, Fernández-Rodriguez A, Rodríguez-Mendiola N, Ponte B, Galeano C, Villafruela JJ, Teruel JL, Burgos FJ, Ortuño J.
    Transplant Proc; 2009 Aug 27; 41(6):2357-9. PubMed ID: 19715918
    [Abstract] [Full Text] [Related]

  • 36. Tacrolimus and azathioprine versus cyclosporine and mycophenolate mofetil after lung transplantation: a retrospective cohort study.
    Celik MR, Lederer DJ, Wilt J, Eser D, Bacchetta M, D'Ovidio F, Sonett JR, Arcasoy SM.
    J Heart Lung Transplant; 2009 Jul 27; 28(7):697-703. PubMed ID: 19560698
    [Abstract] [Full Text] [Related]

  • 37. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov 27; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

  • 38. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
    Jamali S, Sarafnejad A, Ahmadpoor P, Nafar M, Karimi M, Eteghadi A, Yekaninejad MS, Amirzargar AA.
    Hum Immunol; 2019 Sep 27; 80(9):739-747. PubMed ID: 30597187
    [Abstract] [Full Text] [Related]

  • 39. Comparison of tacrolimus and cyclosporin in renal transplantation by the protocol biopsies.
    Töz H, Sen S, Seziş M, Duman S, Ozkahya M, Ozbek S, Hoşcoşkun C, Atabay G, Ok E.
    Transplant Proc; 2004 Sep 27; 36(1):134-6. PubMed ID: 15013324
    [Abstract] [Full Text] [Related]

  • 40. Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy.
    Helmschrott M, Rivinius R, Bruckner T, Katus HA, Doesch AO.
    Drug Des Devel Ther; 2017 Sep 27; 11():1673-1680. PubMed ID: 28652705
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.